← Back to Search

Peripheral Nerve Block (PENG) for Hip Fracture

N/A
Waitlist Available
Led By Michael Halperin
Research Sponsored by Jacobi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 hours.
Awards & highlights

Summary

This will be a feasibility study to see if it feasible to perform the Pericapsular Nerve Group Block for hip fractures in the Emergency Department. In addition, we will look at the efficacy of the block in these 10 patients by measuring pain scores at pre-determine time points for 16 hours.

Eligible Conditions
  • Hip Fracture
  • Acute Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 hours.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 hours. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Scores

Trial Design

1Treatment groups
Experimental Treatment
Group I: Peripheral Nerve Block (PENG)Experimental Treatment1 Intervention
Patients will receive the Pericapsular Nerve Group Block.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pericapsular Nerve Group Block
2021
N/A
~90

Find a Location

Who is running the clinical trial?

Jacobi Medical CenterLead Sponsor
22 Previous Clinical Trials
4,341 Total Patients Enrolled
Michael HalperinPrincipal InvestigatorJacobi Medical Center
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top